Monday, October 6, 2025

Latest

Air Canada: BMO Raises Price Target $34 Off Restrictions Easing

Yesterday, BMO Capital Markets raised their 12-month price target on Air Canada (TSX: AC) to C$34 from C$33 and reiterated their outperform rating on the stock off the back of further easing of travel restrictions worldwide.

Air Canada currently has 17 analysts covering the stock with an average 12-month price target of C$28.63, or a 22% upside. The street high sits at C$35 which comes from Raymond James and the lowest sits at C$12. Out of the 17 analysts, five have strong buy ratings, eight have buy ratings and four have hold ratings.

BMO believes that the travel recovery is now underway but will “undoubtedly face speed bumps,” and that it will have an effect on Air Canada’s share price along the way. They believe that Air Canada is the most efficient and customer-focused airline post-pandemic, and recommend investors to add to their position on a pullback.

They are modeling Canada’s resumption of airline travel after the U.S. They say that the U.S airlines saw significant pent-up demand following their 18-month travel and border restrictions. BMO believes that Canada will start to see the demand re-accelerate this fall and into 2022. Air Canada announced that it is seeing bookings improve for travel within North America and the Atlantic markets for this quarter.

Below you can see the changes BMO made to their second quarter, 2021, and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

PI Financial: US Cannabis Has “Good Growth Prospects”

On Tuesday, PI Financial released their fourth quarter 2021 earnings review on their cannabis sector....

Thursday, April 21, 2022, 02:21:00 PM

Curaleaf: Canaccord Reiterates $22 Price Target Following Secured Note Issuance

On December 16th, Curaleaf Holdings (CSE: CURA) announced the closing of US$425 million 8% senior...

Thursday, December 30, 2021, 04:38:00 PM

Li-Cycle: BMO Cuts Target After Negative Revenues Recorded In Q3

Li-Cycle (NYSE: LICY) recently reported its third-quarter financial results. The company reported revenues of -$2...

Sunday, September 25, 2022, 11:13:00 AM

Canaccord Raises Mind Medicine’s Price Target To $2.00 Following Financing

This morning, Canaccord Genuity raised its 12-month price target on Mind Medicine (NEO: MMED) from...

Monday, November 2, 2020, 10:45:02 AM

Antibe: Canaccord Raises Price Target After Q4 Results

On June 28th, Antibe Therapeutics (TSX: ATE) reported their fourth quarter and year-end financials. The...

Friday, July 2, 2021, 12:18:00 PM